PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Brief, intensive exercise helps patients with panic disorder more than standard care

Brief intermittent intensive exercise found to be better than relaxation therapy in reducing severity and frequency of panic attacks

2026-02-09
(Press-News.org) Panic attacks are sudden bouts of intense fear without an obvious cause. An estimated 10% of people experience at least one panic attack in their lifetime. But between 2% and 3% of the population have such frequent and severe panic attacks that they meet the criteria for the debilitating condition ‘panic disorder’.

The current standard of care for panic disorder is cognitive behavioral therapy (CBT), with or without antidepressants. A technique of CBT with proven efficacy is ‘interoceptive exposure’, where therapists trigger common symptoms of panic attacks like chest pain, sweating, rapid respiration, and a racing heart in a safe, controlled environment. Its aim is to raise tolerance to these symptoms by teaching patients that they aren’t dangerous.

Typically, interoceptive exposure works through office-based exercises such as voluntary hyperventilation or spinning on a chair. But now, researchers have shown that a less artificial and more intense form of interoceptive exposure – brief intermittent intense exercise – is more effective. The results are published in Frontiers in Psychiatry.

“Here we show that a 12-week program of brief intense intermittent exercise can be used as an interoceptive exposure strategy to treat panic disorder patients,” said Dr Ricardo William Muotri, a postdoctoral fellow at the Anxiety Disorders Program of the University of São Paulo Medical School in Brazil.

Trial runs

In this randomized controlled trial, Muotri and colleagues compared the effect of brief, intense intermittent exercise with a form of relaxation therapy commonly used in CBT, in 102 adult women and men diagnosed with panic disorder over a period of 12 weeks.

The participants were divided across two parallel arms and did three sessions every week of their allocated exercise. No drugs were administered to either group throughout the trial.

Patients in the experimental arm began each session with a bout of muscle-stretching, followed by 15 minutes of walking and one to six 30-seconds-long bouts of high-intensity running alternating with 4.5-minutes of active recovery, and ending with additional 15 minutes of walking. Patients in the control arm did segmental muscle contraction exercises in the brachial, scapular, cervical, facial, dorsal, abdominal, and lower limb regions, followed by localized muscle relaxation. All patients wore biometric monitoring devices during the exercises.

The primary endpoint was any change over a period of 24 weeks in a patient’s score on the Panic and Agoraphobia Scale (PAS), which rates the severity of panic symptoms from answers to 13 questions in a questionnaire. Secondary endpoints were analogous changes in scores on questionnaires for anxiety and depression, as well as the self-reported frequency and severity of panic attacks. A psychiatrist, blinded to treatment allocation, assessed outcomes on the endpoints.

Working out

The average PAS score, as well as the scores for anxiety and depression, decreased over time in both arms, but more steeply in the brief intense intermittent exercise arm. Similarly, the frequency and severity of panic attacks decreased more in the brief intense intermittent exercise arm.

The authors concluded that brief, intense intermittent exercise is a more effective method for interoceptive exposure than relaxation therapy for the treatment of panic disorder, with positive effects that last for at least 24 weeks. Because patients reported enjoying this method treatment more than relaxation therapy, engagement and compliance with the treatment are likely to be high.

“Healthcare professionals can adopt brief intermittent intense exercise as a natural and low-cost interoceptive exposure strategy. It doesn’t need to take place in a clinical setting, so that exposure to the symptoms of a panic attack is brought closer to the patient's daily life. It could also be integrated into care models for anxiety and depression disorders,” summarized Muotri.

 

END


ELSE PRESS RELEASES FROM THIS DATE:

How to “green” operating rooms: new guideline advises reduce, reuse, recycle, and rethink

2026-02-09
Reduce, reuse, recycle, and rethink can be applied in Canadian operating rooms (ORs) to increase environmental sustainability, advises a new guideline published in CMAJ (Canadian Medical Association Journal) ​https://www.cmaj.ca/lookup/doi/10.1503/cmaj.251192​. As the Canadian health care system produces almost 5% of the country’s greenhouse gas emissions and 200 000 tonnes of other pollutants, many generated in ORs, it makes sense to focus on reducing these harms. An evidence-based ...

What makes healthy boundaries – and how to implement them – according to a psychotherapist

2026-02-09
In recent years, popular culture has made ‘boundaries’ a saviour, touted as the way to prevent burnout at work and fallout with friends. But how do we make them, and what makes a boundary ‘healthy’? Psychotherapist Lynn Somerfield suggests that maintaining healthy boundaries around relationships, work and personal beliefs is crucial to good mental health. In her new book, The Seeds of Change – How Therapists Cultivate Personal Growth, she draws on patient case histories and insights from her ...

UK’s growing synthetic opioid problem: Nitazene deaths could be underestimated by a third

2026-02-09
Deaths due to synthetic opioids nitazenes have likely been underestimated by up to a third. King’s College London research, published today in Clinical Toxicology, sheds light on the UK’s growing synthetic opioid problem. The presence of nitazenes on the unregulated drug market has risen steeply in the last seven years – prompting UK and international bodies to issue public health warnings about their use.   Nitazenes are a class of synthetic opioids which can have potencies of up to 500 times that of heroin. They can be readily manufactured at low cost. These potent synthetic opioids were ...

How rice plants tell head from toe during early growth

2026-02-07
Tokyo, Japan – Scientists from Tokyo Metropolitan University have uncovered how fertilized rice seeds begin to divide and establish their “body axis.” Using a new imaging method, they discovered that while the first cell divides in an asymmetric way initially, this is followed by random growth and the apparently “collective” determination of a body axis. This is a significant break with known pathways, a rare glimpse into the birth and growth of plant embryos.   A key puzzle in plant science is how plants ...

Scientists design solar-responsive biochar that accelerates environmental cleanup

2026-02-06
Researchers have developed a new strategy to engineer biochar with dramatically enhanced sunlight-driven chemical activity, opening promising pathways for environmental remediation and pollutant transformation. The findings demonstrate how combining biochar with artificially synthesized humic substances can significantly boost its ability to drive light-powered reduction reactions that influence metal cycling and contaminant transformation in natural environments. The study, recently published in Biochar, introduces a co-engineering approach that integrates biochar with artificial humic substances created through a controlled ...

Construction of a localized immune niche via supramolecular hydrogel vaccine to elicit durable and enhanced immunity against infectious diseases

2026-02-06
https://doi.org/10.1016/j.apsb.2025.09.014   This new article publication from Acta Pharmaceutica Sinica B, discusses the construction of a localized immune niche via supramolecular hydrogel vaccine to elicit durable and enhanced immunity against infectious diseases.   Vaccines represent one of the most potent strategies for protecting humans from the threat of infectious diseases. Conventional vaccines elicit acquired immunity by mimicking pathogen characteristics; however, their protective efficacy is limited by inadequate spatiotemporal control of ...

Deep learning-based discovery of tetrahydrocarbazoles as broad-spectrum antitumor agents and click-activated strategy for targeted cancer therapy

2026-02-06
https://doi.org/10.1016/j.apsb.2025.10.005   This new article publication from Acta Pharmaceutica Sinica B, discusses the deep learning-based discovery of tetrahydrocarbazoles as broad-spectrum antitumor agents and click-activated strategy for targeted cancer therapy. Phenotypic screening has played an important role in discovering innovative small-molecule drugs and clinical candidates with unique molecular mechanisms of action. However, conducting cell-based high-throughput screening from vast compound libraries is extremely time-consuming and expensive. Fortunately, deep learning has provided a new paradigm for identifying ...

DHL-11, a novel prieurianin-type limonoid isolated from Munronia henryi, targeting IMPDH2 to inhibit triple-negative breast cancer

2026-02-06
https://doi.org/10.1016/j.apsb.2025.10.031   This new article publication from Acta Pharmaceutica Sinica B, discusses DHL-11, a novel prieurianin-type limonoid isolated from Munronia henryi, targeting IMPDH2 to inhibit triple-negative breast cancer.   Triple-negative breast cancer (TNBC) is the most aggressive subtype of breast cancer, characterized by the poorest prognosis, and poses a significant threat to women's health. In this study two novel prieurianin-type limonoids extracted from Munronia henryi were identified, one of which, named DHL-11, exhibited antitumor activity ...

Discovery of SARS-CoV-2 PLpro inhibitors and RIPK1 inhibitors with synergistic antiviral efficacy in a mouse COVID-19 model

2026-02-06
https://doi.org/10.1016/j.apsb.2025.09.026   This new article publication from Acta Pharmaceutica Sinica B, discusses the discovery of SARS-CoV-2 PLpro inhibitors and RIPK1 inhibitors with synergistic antiviral efficacy in a mouse COVID-19 model. SARS-CoV-2 continues to propagate globally, posing non-negligible risks of severe COVID-19. Although several clinical antivirals and immunosuppressants offer crucial protection, there is a persistent need for additional therapeutic options to counter emerging viral variants and drug ...

Neg-entropy is the true drug target for chronic diseases

2026-02-06
https://doi.org/10.1016/j.apsb.2025.11.026 This new article publication from Acta Pharmaceutica Sinica B, discusses how neg-entropy is the true drug target for chronic diseases. Molecular mechanisms of chronic diseases are complicated, and this impedes drug target identification and subsequent drug discovery. Entropy increase in human body can be considered the root cause of chronic diseases. Accordingly, the inherent neg-entropic mechanisms, for instance the homeostatic mechanisms for metabolism, immunity, self-healing, etc., are true drug targets. Only very few ...

LAST 30 PRESS RELEASES:

Brief, intensive exercise helps patients with panic disorder more than standard care

How to “green” operating rooms: new guideline advises reduce, reuse, recycle, and rethink

What makes healthy boundaries – and how to implement them – according to a psychotherapist

UK’s growing synthetic opioid problem: Nitazene deaths could be underestimated by a third

How rice plants tell head from toe during early growth

Scientists design solar-responsive biochar that accelerates environmental cleanup

Construction of a localized immune niche via supramolecular hydrogel vaccine to elicit durable and enhanced immunity against infectious diseases

Deep learning-based discovery of tetrahydrocarbazoles as broad-spectrum antitumor agents and click-activated strategy for targeted cancer therapy

DHL-11, a novel prieurianin-type limonoid isolated from Munronia henryi, targeting IMPDH2 to inhibit triple-negative breast cancer

Discovery of SARS-CoV-2 PLpro inhibitors and RIPK1 inhibitors with synergistic antiviral efficacy in a mouse COVID-19 model

Neg-entropy is the true drug target for chronic diseases

Oxygen-boosted dual-section microneedle patch for enhanced drug penetration and improved photodynamic and anti-inflammatory therapy in psoriasis

Early TB treatment reduced deaths from sepsis among people with HIV

Palmitoylation of Tfr1 enhances platelet ferroptosis and liver injury in heat stroke

Structure-guided design of picomolar-level macrocyclic TRPC5 channel inhibitors with antidepressant activity

Therapeutic drug monitoring of biologics in inflammatory bowel disease: An evidence-based multidisciplinary guidelines

New global review reveals integrating finance, technology, and governance is key to equitable climate action

New study reveals cyanobacteria may help spread antibiotic resistance in estuarine ecosystems

Around the world, children’s cooperative behaviors and norms converge toward community-specific norms in middle childhood, Boston College researchers report

How cultural norms shape childhood development

University of Phoenix research finds AI-integrated coursework strengthens student learning and career skills

Next generation genetics technology developed to counter the rise of antibiotic resistance

Ochsner Health hospitals named Best-in-State 2026

A new window into hemodialysis: How optical sensors could make treatment safer

High-dose therapy had lasting benefits for infants with stroke before or soon after birth

‘Energy efficiency’ key to mountain birds adapting to changing environmental conditions

Scientists now know why ovarian cancer spreads so rapidly in the abdomen

USF Health launches nation’s first fully integrated institute for voice, hearing and swallowing care and research

Why rethinking wellness could help students and teachers thrive

Seabirds ingest large quantities of pollutants, some of which have been banned for decades

[Press-News.org] Brief, intensive exercise helps patients with panic disorder more than standard care
Brief intermittent intensive exercise found to be better than relaxation therapy in reducing severity and frequency of panic attacks